Mednax (MD) Misses Q1 EPS by 2c; Guides Q2 EPS Below Views

Mednax (NYSE: MD) reported Q1 EPS of $0.98, $0.02 worse than the analyst estimate of $1.00. Revenue for the quarter came in at $422.6 million versus the consensus estimate of $423.46 million.

Mednax sees Q2 2012 EPS of $1.15-$1.21, versus the consensus of $1.28.

For earnings history and earnings-related data on Mednax (MD) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
• UBS: 'We Believe Dollar Tree (DLTR) is Turning From a Transformation to a Growth Story'
• Tesla to launch Cybercab in Austin this month - report